Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NOVT
NOVT logo

NOVT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Novanta Inc (NOVT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
138.310
1 Day change
1.49%
52 Week Range
149.950
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Novanta Inc (NOVT) does not present a strong buy opportunity for a beginner, long-term investor at this moment. While the stock has bullish technical indicators and hedge funds are increasing their positions, the lack of recent positive news, mixed financial performance, and no proprietary trading signals suggest waiting for a better entry point. The stock's pre-market price is stable but lacks momentum, and the options data indicates a bearish sentiment with a high Open Interest Put-Call Ratio.

Technical Analysis

The technical indicators are moderately bullish. The MACD is above 0 and positively contracting, suggesting upward momentum. The RSI is neutral at 78.076, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 135.512 and 138.899, while support levels are at 124.544 and 121.157. However, the stock's candlestick pattern indicates a 50% chance of a -0.56% decline in the next day and further declines over the next week and month.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
9

Positive Catalysts

  • Hedge funds are increasing their positions significantly, with a 140% increase in buying activity over the last quarter. Analysts have upgraded the stock to 'Outperform' with a price target of $144, citing valuation and minimal Middle East exposure as positives.

Neutral/Negative Catalysts

  • No recent news or event-driven catalysts have been reported. The financial performance shows declining EPS (-2.17% YoY) and gross margin (-4.71% YoY), which could weigh on long-term growth.

Financial Performance

In Q4 2025, revenue increased by 8.52% YoY to $258.35M, and net income rose by 6.12% YoY to $17.47M. However, EPS dropped by 2.17% YoY to 0.45, and gross margin declined by 4.71% YoY to 40.7%. These mixed results indicate some growth but also highlight margin pressures.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are moderately positive on the stock. Baird upgraded the stock to 'Outperform' with a price target of $144, down from $150, citing valuation and minimal Middle East exposure as positives. Another analyst raised the price target to $150 from $138 but maintained a Neutral rating, indicating cautious optimism.

Wall Street analysts forecast NOVT stock price to rise
Analyst Rating
0
Wall Street analysts forecast NOVT stock price to rise
Buy
Hold
Sell
0
Current: 138.310
sliders
Low
0
Averages
0
High
0
0
Current: 138.310
sliders
Low
0
Averages
0
High
0
Baird
Quinn Fredrickson
Neutral
to
Outperform
upgrade
$150 -> $144
AI Analysis
2026-03-30
Reason
Baird
Quinn Fredrickson
Price Target
$150 -> $144
AI Analysis
2026-03-30
upgrade
Neutral
to
Outperform
Reason
Baird analyst Quinn Fredrickson upgraded Novanta to Outperform from Neutral with a price target of $144, down from $150. The firm remains positive on the advanced industrial technology group, saying the sector's Middle East exposure is minimal while cyclical indicators continue to point towards improvement in 2026 and 2027. Baird sees the recent pullback in the stocks as a buying opportunity. It cites valuation for the upgrade of Novanta following the recent selloff.
Baird
Robert Mason
Neutral
maintain
$138 -> $150
2026-02-25
Reason
Baird
Robert Mason
Price Target
$138 -> $150
2026-02-25
maintain
Neutral
Reason
Baird analyst Robert Mason raised the firm's price target on Novanta to $150 from $138 and keeps a Neutral rating on the shares. The firm updated its model following Q4 results which suggests the company is positioned for accelerating sales and margins.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NOVT
Unlock Now

People Also Watch